Discussing code status is a critical part of the larger goals of care discussion. The challenge is that code status discussions often happen in emotional and high-stake situations. Our previous ...

CRAFTing a response: expanding support options available for families affected by substance use By Dr. Heather Fulton on November 26, 2024 ...

For classic presentations of gout and diagnosis please see: Shojania K, Amiri N. Part 1: Diagnosing gout in primary care settings: do we have to tap? This Changed My Practice, UBC CPD. March 31, 2015.

Experience of imposter feelings is linked to poor mental health outcomes such as anxiety, depression, and burnout and results in lower professional fulfillment. There may not be a “cure” for imposter ...

Presbyopia is a condition that affects all people, often becoming noticeable in the 40s. With age the crystalline lens hardens and begins to lose its elasticity, making the process of accommodation ...

Management of Helicobacter pylori in 2023: who should be tested, treated, and how By Dr. Sander Veldhuyzen van Zanten on August 9, 2023 ...

Offering Brief Behavioral Therapy for insomnia (BBTi) in primary care settings By Vinicio Delgado and Dr. Wayne Lai on July 19, 2023 ...

Heart failure is the third leading cause of hospitalization in Canada and leads to readmission in 1 in 5 patients within 30 days after discharge. Iron deficiency (with or without anemia) is an ...

While I’ve been hard on newer medications like SGLT2i for their relatively small benefit in lower-risk patients, recent systematic reviews show that our traditional interventions are no better, and ...

Help, “hive” got a rash! – Article 2: Practical tips in the management of chronic spontaneous urticaria (CSU) By Drs. Kevin Lee and Persia Pourshahnazari on May 31, 2023 ...

In the past, I would frame conversations with patients about pharmacotherapy for tobacco use disorder in terms of “smoking cessation” and “helping patients quit.” In line with this approach, I would ...

Polycystic ovary syndrome is the most common endocrinopathy in women of reproductive age. It affects 8%–13% of young women and its symptoms are some of the most prevalent concerns that community ...